Launch in context
SMART App Launch provides patient context and authorizes the workflow through the EHR.
SMART on FHIR medication review
A focused SMART app that reviews active medications from the patient chart and surfaces warning signals clinicians can scan before acting.
RxOpsis launches in context, reads the selected patient's medication data, normalizes drug identity, and presents clear warning summaries without moving tokens into the browser.
SMART App Launch provides patient context and authorizes the workflow through the EHR.
The backend requests active medication resources from the FHIR server for the selected patient.
Medication names and codings are mapped toward RxNorm identifiers where available.
Warnings are summarized by severity, source, and relevant medications in a compact review surface.
RxOpsis is designed as a decision-support companion: fast to launch, plain about evidence sources, and easy to extend as validated drug interaction services are added.
Runs from the current SMART patient context instead of relying on manual drug entry.
Keeps access tokens on the backend and gives the UI only the summary it needs.
Shows warning provenance so clinicians can distinguish label-based signals from curated DDI data.
The app is structured for a hosted launch service at app.rxopsis.com, with a separate public website at www.rxopsis.com. That keeps public content and authenticated clinical workflows under one domain family while preserving clean operational boundaries.
RxOpsis brings a concise medication warning review into SMART-enabled EHR sessions.